IFNγR−/− Roquinsan/san mice showed prevented lupus development, evidenced by low number of Tfh cells and reduced ANA production, whereas IFNγR+/+ Roquinsan/san mice upregulated the Bcl-6 expression in Tfh cells (136). The gene discussed is BCL6; the disease is systemic lupus erythematosus.